Showing results (1-10 of 350) with videos related to
Sort By:
Pageof 35
Open Biology|May 14, 2020
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabineRoberta Valsecchi, Nadia Coltella, Daniela Magliulo, et al.Hematology. American Society of Hematology. Education Program|December 13, 2012
A look into the future: can minimal residual disease guide therapy and predict prognosis in chronic lymphocytic leukemia?Paolo GhiaLeukemia|April 28, 2018
Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatmentsPaolo Ghia, Andy RawstronImmunology Letters|October 8, 2013
Reprogramming cell death: BCL2 family inhibition in hematological malignanciesLydia Scarfò, Paolo GhiaFrontiers in Oncology|January 4, 2021
Modeling the Leukemia Microenviroment In VitroCristina Scielzo, Paolo GhiaSeminars in Oncology|April 5, 2016
What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challengesLydia Scarfò, Paolo GhiaSeminars in Oncology|April 18, 2006
The origin of B-cell chronic lymphocytic leukemiaPaolo Ghia, Federico Caligaris-CappioHematology/Oncology Clinics of North America|August 25, 2004
The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative modelFederico Caligaris-Cappio, Paolo GhiaJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?Federico Caligaris-Cappio, Paolo GhiaPageof 35